Axon Therapies
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
345 Park Ave S, New York, New York, 1001...Website
www.axontherapies.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Axon Therapies
Axon Therapies is a private MedTech company developing minimally invasive therapies that address the root causes of heart failure. Its lead innovation, SAVM using the Satera Ablation System, enables targeted ablation of the overactive sympathetic nervous system without the need for an implant.Explore more
Axon Therapies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Axon Therapies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Axon Therapies had a recent Job posting/layoffs
Check out if Axon Therapies is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Axon Therapies, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Axon Therapies has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Axon Therapies
Funding: Get notified immidiatlly once Axon Therapies has new funding data
Product Launch: Get notified when Axon Therapies launches new products
Earning: See what the market has to say on Axon Therapies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Axon Therapies
Find more new buyers
Compare Similar Companies to Axon Therapies
Compare insights from companies similar to Axon Therapies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Axon Therapies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Axon Therapies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Axon Therapies.
Axon Therapies financials insights
Gather financial insights about Axon Therapies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$32M
Axon Therapies Tech Stack
A closer look at the technologies used by Axon Therapies
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Axon Therapies has announced that Zoar Engelman has joined the organization as Chief Executive Officer.
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Axon Therapies News & Media
Axon Therapies Closes $32M Series A
NEW YORK, NY, Axon Therapies, a clinical-stage medical device company pioneering a new approach to treating heart failure, has announced the close of an oversubscribed $32 million Series A financing.Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
Funding supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Axon Therapies, a clinical-stage medical device company pioneering a new approach to treating...Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy
REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months SAVM procedure quick and easy to perform with high success rate and no significant increase in procedure-related...Axon Therapies Cohort Study Extends Benefit to 6 months with Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
SANTA CLARA, Calif., March 22, 2023 /PRNewswire/ -- Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced positive 6-month results from a roll-in cohort for their feasibility IDE trial, REBALANCE-HF. The latest data is consistent with prior...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Axon Therapies
Sign Up For FreeTo access detailed company insights
Axon Therapies is a private MedTech company developing minimally invasive therapies that address the root causes of heart failure. Its lead innovation, SAVM using the Satera Ablation System, enables targeted ablation of the overactive sympathetic nervous system without the need for an implant.... Read More
